Immudex is a life science company and trusted partner of scientists spearheading the global adoption of precision immune monitoring. Immudex’s Dextramer® technology enables superior detection of antigen-specific immune cells. Immudex’s product portfolio allows scientists to investigate diverse types of immune cells, including T cells, non-conventional T cells, B cells and CAR cells using flow cytometry, next generation sequencing and single-cell multi-omics.
Looking for a particular Immudex employee's phone or email?
Immudex Questions
The Immudex annual revenue was $5 million in 2026.
Peter Ifversen is the COO of Immudex.
40 people are employed at Immudex.
The NAICS codes for Immudex are [32, 325, 3254, 32541, 325413].
The SIC codes for Immudex are [28, 283].
Top Immudex Employees
-
Peter Ifversen
Chief Operating Officer at Immudex
Copenhagen, DK32 -
Liselotte Brix
Chief Scientific Officer at Immudex
Copenhagen, DK22 -
Alessandra Audia
Vice President, North America at Immudex
Philadelphia, PA, US42 -
Stephen Haley
Vice-President and Director at Immudex
Reston, VA, US25 -
Jamil El-Ali
Member Board of Directors at Immudex
Copenhagen, DK12 -
21
-
22
-
Mohammad Salem
Head of Sales; EU at Immudex
Copenhagen, DK25 -
Chris Chuckran
Immune Monitoring Specialist at Immudex
United States24 -
21
Related Companies
